According to recently conducted experiments, cannabis could be regarded as an effective solution for patients identified as having multiple sclerosis. While at first the symptomatic improvements experienced by patients with multiple sclerosis who've been administered cannabinoid goods were regarded as decided solely by psychological factors, later studies have revealed that cannabis actually reduces muscular stiffness and spasms distinctive to multiple sclerosis sufferers. The benefic effects of cannabis on patients with multiple sclerosis had been established by short term and long-term controlled health studies.
In 2003, a group of scientists from the Peninsula Medical School in Exeter, UK have made public the results of a compilation of short-term and long-term studies on the consequences of cannabinoids among people with multiple sclerosis. The previously conducted studies involved the active participation of approximately 600 patients with advanced stage multiple sclerosis. The people were split in two distinct groups: the very first group was given cannabinoid compounds in the same doses, while the next group received placebo expired pills with a period of 15 days. By the end of the experiment, the bulk of patients that have been administered cannabinoids felt a lot of symptomatic improvements, having less muscular pain shark tank and cbd gummies to quit smoking (linked here) being confronted with gentler muscular spasticity (less pronounced muscular spasm). Unlike the group that was given cannabinoid compounds with the whole period of the study, the control group (patients that received placebo medications) skilled no improvements in their overall condition.
In order to be able to establish the relevancy of the results also to discard some doubts concerning the efficiency of cannabis in ameliorating the indications of multiple sclerosis, the analysis was later repeated. The ulterior study was performed over a period of 12 months, and involved the participation of the exact same subject areas. But, this time the participants had been divided into three distinct groups instead of two as in the case of the earlier experiment. The very first team received pills of D9 tetrahydrocannabinol (THC) - the active component of cannabis, the second group received natural cannabis extracts, while the third group received placebo medicines.
At the conclusion of the test, patients were carefully evaluated as well as analyzed by a team of neurologists and physiotherapists. The top results have been obtained among the patients belonging to the pioneer study group, the majority of subjects that have received equal doses of THC encountering considerable changes in the symptoms of theirs. The patients in the second study group encountered small changes in the symptoms of theirs, while the patients in the final group experienced no changes in the condition of theirs.
Inspite of the fact these studies clearly suggest that cannabis is an effective treatment for multiple sclerosis, medical researchers aren't still convinced that cannabinoids is successfully used in the treatment of many sclerosis. Nevertheless, after performing additional studies on the issue and much more elaborate research, doctors is possible to consider to introduce cannabinoid compounds in the curing of several sclerosis in the future.